We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-11.07%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$26.1M
(-18%)
Cap. Flow
-$2.71M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
29.75%
Holding
113
New
4
Increased
25
Reduced
23
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.12M |
| 2 |
SRXH
SRX Global
SRXH
|
+$1.01M |
| 3 |
Rockwell Medical
RMTI
|
+$452K |
| 4 |
VEV
Vicinity Motor Corp. Common Stock
VEV
|
+$446K |
| 5 |
BNC
CEA Industries
BNC
|
+$436K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSLT
CASTLIGHT HEALTH, INC.
CSLT
|
+$2.36M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$2.12M |
| 3 |
Standard BioTools
LAB
|
+$1.59M |
| 4 |
UPH
UpHealth, Inc.
UPH
|
+$868K |
| 5 |
Vericel Corp
VCEL
|
+$544K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.91% |
| 2 | Technology | 17.36% |
| 3 | Industrials | 8.45% |
| 4 | Consumer Staples | 7.61% |
| 5 | Communication Services | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
NeoGenomics
NEO
$2.02B
| $1.85M | 1.52% |
152,550
-3,000
| -2% | -$63.1K |
|
|
ASPU
27
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.83M | 1.5% |
1,130,375
-14,000
| -1% | -$24K |
|
|
CTLP
28
DELISTED
Cantaloupe
CTLP
| $1.75M | 1.43% |
258,125
-5,100
| -2% | -$38.7K |
|
|
SRXH
29
SRX Global
SRXH
$27.1M
| $1.71M | 1.4% |
343
+185
| +117% | +$1.01M |
|
30
Target
TGT
$67.1B
| $1.65M | 1.35% |
7,779
| – | – |
|
31
Exagen
XGN
$161M
| $1.61M | 1.32% |
200,975
+1,500
| +0.8% | +$12.9K |
|
32
Castle Biosciences
CSTL
$929M
| $1.49M | 1.22% |
33,170
| – | – |
|
33
General Mills
GIS
$19.2B
| $1.45M | 1.19% |
21,350
| – | – |
|
|
34
Vericel Corp
VCEL
$2.32B
| $1.44M | 1.18% |
37,567
-15,070
| -29% | -$544K |
|
35
QuickLogic
QUIK
$245M
| $1.36M | 1.11% |
246,782
+4,997
| +2% | +$25.4K |
|
36
Elutia
ELUT
$38.5M
| $1.35M | 1.11% |
227,729
| – | – |
|
37
Achieve Life Sciences
ACHV
$684M
| $1.32M | 1.08% |
174,600
| – | – |
|
|
SMED
38
DELISTED
Sharps Compliance Corp
SMED
| $1.29M | 1.06% |
218,455
| – | – |
|
|
AKTS
39
DELISTED
Akoustis Technologies Inc
AKTS
| $1.26M | 1.04% |
194,450
+1,500
| +0.8% | +$8.92K |
|
|
AUGX
40
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $1.26M | 1.03% |
429,000
| – | – |
|
|
PDCO
41
DELISTED
Patterson Companies, Inc.
PDCO
| $1.21M | 0.99% |
37,450
-500
| -1% | -$14.8K |
|
42
Bristol-Myers Squibb
BMY
$130B
| $1.21M | 0.99% |
16,508
| – | – |
|
43
Ciena
CIEN
$57.9B
| $1.09M | 0.89% |
18,000
-250
| -1% | -$16.4K |
|
|
BIOL
44
DELISTED
Biolase, Inc.
BIOL
| $1.08M | 0.89% |
1,226
+7
| +0.6% | +$6.46K |
|
45
Perspective Therapeutics
CATX
$335M
| $1.02M | 0.83% |
279,850
-250
| -0.1% | -$912 |
|
46
Merck
MRK
$317B
| $987K | 0.81% |
12,025
| – | – |
|
47
Village Farms International
VFF
$238M
| $961K | 0.79% |
182,050
+24,500
| +16% | +$131K |
|
48
3M
MMM
$93.9B
| $954K | 0.78% |
7,662
| – | – |
|
49
AT&T
T
$158B
| $941K | 0.77% |
52,744
+1,986
| +4% | +$36.7K |
|
50
Gilead Sciences
GILD
$164B
| $937K | 0.77% |
15,767
| – | – |
|
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Perkins Capital Management held 113 positions worth $122M, down 18% from $148M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Perkins Capital Management's Q1 2022 filing shows 4 new, 25 increased, 23 reduced and 3 closed positions. Its largest new stake was Vicinity Motor Corp. Common Stock: 133,000 shares worth $319K. The largest sale was CASTLIGHT HEALTH, INC., an estimated $2.36M.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, down from 58% a quarter earlier, followed by Technology and Industrials.
- Perkins Capital Management's largest Q1 2022 buy was Vicinity Motor Corp. Common Stock: 133,000 shares worth $319K.
- Perkins Capital Management added most to Advanced Micro Devices in Q1 2022, an estimated $2.12M increase.
- Perkins Capital Management's biggest Q1 2022 reduction was Standard BioTools, cutting an estimated $1.59M.
- Perkins Capital Management fully exited CASTLIGHT HEALTH, INC. in Q1 2022, selling an estimated $2.36M.
- Perkins Capital Management's ten largest holdings make up 30% of its $122M portfolio in Q1 2022.
- Perkins Capital Management opened 4 new positions and closed 3 in Q1 2022.
- Perkins Capital Management's portfolio value fell 18% quarter-over-quarter to $122M.
Based on Perkins Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.